George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Still a chance (maybe a slim one) that we could get a trading update.
If I remember correctly 1 share traded was supposed to mean an RNS was due. Not that I was a follower of the theory but look, we got 2 lol.
So it seems there was a trade of 1 share yesterday. So what is the MM signal for 1 share. It must be something.
For the second time this week. Always a lot of argument what it means, but there is more significance in the NT trades period IMHO
And here is the second PME
... and there's the second. Very strange trading pattern into the close, hope there's more to it than that. Guess we'll find out at 7.00am now.
The thing I like about PXS there is there is no leaky information that gets out. IF is really good on this. But I think we have some big news due and the MMS are getting ready. IMO of course
You were right, first PME posted.
There's something afoot kievsky, keep an eye open for red dots.
Could not buy 1 share for the last 15 minutes with HL
darkcorner, re question 3. Surprised no-one has pointed out that our trading partner is DSM, so in effect we already are one of the majors. And yes, it absolutely is possible we could enjoy a big slice of the pie. Like others on here though, I've waited a long time to see it...
But no mention of ff. https://www.by-health.com/en/aboutus/news/4329/
Strange, 0.97 to sell and 0.95 to buy, but buy and sell are NT still. Bet there are two PME later
NT to buy and sell on HL.
Let's just say it's been a while.
A poster is living in someone’s head rent free.
Yep.
We all know that a first truly global brand is the key. If you believe it'll happen, invest accordingly, if you don't, ditto. In the main, that's what we have here, just the odd one who got timing all wrong and wants to punish the rest of us for ever and a day. Really bad manners IMHO
Thanks both.
So assuming that covid has played its part in any delays, as it has across the world, given the statement regarding blue cap being achieved following trials in 2019, if things get moving we could be close. You guys been invested for long?
3. Absolutely everyone has a view on potential, upwards from colbaltblue to infinity.
That last £1m fundraising was described as a significant derisking event. Make of that what you will.
1. the last we heard BY-HEALTH were intending to make its first submission to the SAMR for Fruitflow® in February 2019.
https://provexis.org/wp-content/uploads/2018/12/PXS_2018-11_Provexis_plc_30-Sep-18_interims_31-Dec-18.pdf
2. plenty of money in the bank.
https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1436931
3. Good question.
Hi all, been quietly watching this one from the sidelines for years now, interested in taking a position however haven't taken the plunge yet, was wondering if somebody would answer a couple of questions if they have time.
Firstly, in terms of the blue cap status, from what I can find when the process was amended a few years back, it was to make it smoother and more efficient. Also from what I can find, to achieve this status shouldn't take anymore than a couple of years, but we're approaching 5 years in this quest? Have I got that right or does someone have a take on why it hasn't happened yet?
Financially, their situation is improving and has been for years although on a slow basis, so another placing looks imminent when there's only 150k left in the bank. From history their doesn't seem to be any rhyme or reason to when these happen, although .7 to .75 looks like a safe bet.
Thirdly, does anyone have any views about the potential here. A 20m cap is nothing in reality in the scheme of things, but given the firm grip that majors have on a market such as this, do people think its plausible that we would be able to jump in and steal marketshare here. The benefits of the product seem to have a huge potential market across the globe, however again is it actually viable for this to emerge as a viable business?
Any thoughts are welcomed!
CB,
You are absolutely 100% correct this time. Fasten your seat belt for the take off probably rockier than SAR.
Could be transformational!!
gixer,
Thanks for the info. Looks like more study for blue hat. Probably something very big is brewing at the background.
Thx Gixer
looks like more grist for the potentially new blood aggregation bluecap category mill?
W$